Royalty Pharma plc (RPRX) CEO Pablo Legorreta on Q4 2020 Results - Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q4 2020 Earnings Conference Call February 17, 2021 8:00 AM ET

Company Participants

George Grofik - Senior Vice President, Head of Investor Relations and Communications
Pablo Legorreta - Founder and Chief Executive Officer
Jim Reddoch - Executive Vice President and Co-Head of Research and Investments
Marshall Urist - Executive Vice President and Co-Head of Research and Investments
Terry Coyne - Executive Vice President and Chief Financial Officer
Chris Hite - Vice Chairman

Conference Call Participants

Steve Scala - Cowen
Geoff Meacham - Bank of America
Chris Schott - JP Morgan
Greg Gilbert - Truist Securities
Terence Flynn - Goldman Sachs
Mike DiFiore - Evercore
David Risinger - Morgan Stanley

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Fourth Quarter 2020 Financial Results Conference Call.

I would now like to turn the call over to George Grofik, Senior Vice President, Head of Investor Relations and Communications. Please go ahead, sir.

George Grofik

Thank you, operator, and good morning and good afternoon to everyone on the call. Thank you for joining us to review Royalty Pharma's fourth quarter results. You can find the slides to this call on the Investors page of our website at royaltypharma.com.

Moving to Slide 3, I would like to remind you that information presented in this call contains forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. I refer you to our S-1, Prospectus on file with the SEC for a description of these risk factors.

And with that, please advance to Slide 4. Our speakers on the call today are; Pablo Legorreta, Founder and Chief Executive Officer; Jim Reddoch, EVP, Co-Head of Research and Investments and Chief Scientific Officer; Marshall Urist, EVP, Co-Head of Research and Investments and Terry Coyne, EVP, Chief Financial Officer. Pablo will discuss the